Deerfield Management Company, L.P. (Series C) Apellis Pharmaceuticals, Inc. Transaction History

Deerfield Management Company, L.P. (Series C)

$4.04 Billion
Q4 2024

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$76.68 - $93.31 $24 Million - $29.2 Million	313,289 New	313,289 $28.5 Million
Q1 2022 May 16, 2022	SELL	$35.46 - $54.12 $12.2 Million - $18.6 Million	-343,213 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$30.74 - $49.16 $10.6 Million - $16.9 Million	343,213 New	343,213 $16.2 Million
Q1 2018 May 15, 2018	SELL	$14.01 - $26.02 $7.19 Million - $13.3 Million	-513,000 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$12.71 - $21.7 $6.52 Million - $11.1 Million	513,000	513,000 $11.1 Million

Others Institutions Holding APLS

# of Institutions

302

Shares Held

123M

Call Options Held

2.63M

Put Options Held

845K

Avoro Capital Advisors LLC New York, NY

12.2M
Shares

$336 Million
5.68% of portfolio
Eco R1 Capital, LLC San Francisco, CA

11.9M
Shares

$327 Million
17.73% of portfolio
Wellington Management Group LLP Boston, MA

11.8M
Shares

$325 Million
0.07% of portfolio
Vanguard Group Inc Valley Forge, PA

10M
Shares

$276 Million
0.01% of portfolio
Morgan Stanley New York, NY

9.63M
Shares

$265 Million
0.02% of portfolio

View Full List

About Apellis Pharmaceuticals, Inc.

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $3.02B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

More about APLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deerfield Management Company, L.P. (Series C), based on Form 13F filings with the SEC.

News

Stay updated on Deerfield Management Company, L.P. (Series C) with notifications on news.

Account